-
All
-
Affiliates
-
Career Resources
-
Medical Conditions
-
Practice Settings
Achievement of Targets in T2DM Varies by Season
There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 Read more
Behavioral therapy ‘missing ingredient’ for digital health success in diabetes
Digital health tools designed to improve disease management for patients with diabetes often have little effect on long-term health outcomes, likely due to an insufficient emphasis on Read more
Advanced glycation end product accumulation, insulin resistance share ‘two-way’ relationship
Insulin resistance and the accumulation of advanced glycation end products in the skin have a “two-way” relationship for adults with type 1 diabetes, according to findings published in Read more
Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus
Aim: To evaluate the association between skin advanced glycation end products and insulin resistance in Type 1 diabetes. Source:Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes Read more
Protein released from fat after exercise improves glucose
Exercise training causes dramatic changes to fat. Additionally, this ‘trained’ fat releases beneficial factors into the bloodstream. Source: Protein released from fat after exercise improves Read more
Multiple CGM systems provide comparable performance, usability
Three continuous glucose monitoring systems were shown to provide similar accuracy in adults with type 1 diabetes compared with self-monitoring blood glucose, according to findings published in the Journal of Diabetes Science and Technology. Source: Multiple CGM systems provide comparable performance, Read more
No CV benefit to tight glycemic control in diabetes with heart disease
Investigators analysed a subset of people living with type 2 diabetes and pre-existing cardiovascular disease (CVD) to see whether intensive glucose control, versus standard of care, improved cardiovascular outcomes. Their literature review concluded that there was no difference in the risk of cardiovascular events in adults with type 2 diabetes and CVD allocated to intensive... Read more Read more
Closed-Loop Insulin Delivery Safe for Use in Very Young Children With T1D – Endocrinology Advisor
Unrestricted home use of day and night hybrid closed-loop insulin is safe and feasible for very young children. Source: Closed-Loop Insulin Delivery Safe for Use in Very Young Children With Read more
Microchip could identify type 1 diabetes faster than current diagnostic methods
A new method of identifying warning signs of type 1 diabetes earlier may pave the way for methods that might prevent the condition from developing. US scientists from Stanford and the Read more
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression
Kidney disease has been recognized as a complication of type 2 diabetes mellitus (T2DM) since the 1950s, developing in approximately 35% of patients with T2DM and affecting as many as 50% of patients with diabetes through a 20 years’ duration. The prevalence of diabetic kidney disease (DKD) in the United States increased from 1988 to... Read more Read more